| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.69 | 0.006 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.006 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 97 | 0.01 |